Healthcare M&A dealmaking has soared to USD 92 bn so far this year via 464 deals and is up 63% from the same period last year (USD 56.4bn via 392 deals), according to dealogic.
The spike comes amidst a booming global M&A market that has world-wide transactions already at the USD 593.4bn, the highest year to date total since 2007 (USD 677.1bn).
Americas is driving the increase in Healthcare M&A volume with USD 77.9bn via 219 deals so far in 2015, up 49% from 2014 and is the highest year to date volume on record. The total Americas targeted M&A volume was dominated by AbbVie’s pending USD 21.0bn acquisition of Pharmacyclics Inc, announced on March 4. Asia Pacific targeted Healthcare M&A volume is now higher than in EMEA.